APO Research
Talk to an analyst

APO RESEARCH · REPORT

Transglutaminase

Transglutaminase is an enzyme that catalyzes the formation of isopeptide bonds between proteins.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Transglutaminase is an enzyme that catalyzes the formation of isopeptide bonds between proteins.

Its cross-linking property is widely used in various processes: to manufacture cheese and other dairy products, in meat processing, to produce edible films and to manufacture bakery products. Transglutaminase has considerable potential to improve the firmness, viscosity, elasticity and water-binding capacity of food products.

At this stage, the production technology is mainly microbial fermentation method. And Ajinomoto is the first enterprises to achieve commercial production with microbial fermentation method in the end of 1980s.

Selected research

Market Outlook & Growth Opportunities

Global Transglutaminase Market Outlook and Growth Opportunities 2026

9 January 2026198 pages

Choose your research edition.

Industry ResearchTransglutaminase Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Transglutaminase Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Transglutaminase Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Transglutaminase Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Transglutaminase Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

Transglutaminase is an enzyme that catalyzes the formation of isopeptide bonds between proteins.

Its cross-linking property is widely used in various processes: to manufacture cheese and other dairy products, in meat processing, to produce edible films and to manufacture bakery products. Transglutaminase has considerable potential to improve the firmness, viscosity, elasticity and water-binding capacity of food products.

At this stage, the production technology is mainly microbial fermentation method. And Ajinomoto is the first enterprises to achieve commercial production with microbial fermentation method in the end of 1980s.

Read the full market overview

Global Transglutaminase main manufactuers include Taixing Dongsheng, Yiming Biological and Ajinomoto, totally accounting for 79% of the market. Europe is the largest market, with a share over 36%. As for the types of products, it can be divided into less than 100 U/g, 100 U/g – 200 U/g and more than 200 U/g. The most common type is 100 U/g – 200 U/g, with a share over 49%. As for the types of application, it is widely used in meat field, fish field, dairy field, flour field and others. The most common application is fish field, with a share over 23%.

This report provides an overview of the global Transglutaminase market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Transglutaminase and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Transglutaminase sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Transglutaminase market size, projected growth trends, production technologies, key applications, and end-use industries.

Transglutaminase Segment by Company

Ajinomoto

TFI GmbH

Micro-Tech Foods Ingredients

BDF Natural Ingredients

Yiming Biological

Taixing Dongsheng

Kinry

Pangbo Biological

Transglutaminase Segment by Type

Less Than 100 U/g

100 U/g – 200 U/g

More Than 200 U/g

Transglutaminase Segment by Application

Meat

Fish

Dairy

Flour

Others

Transglutaminase Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Transglutaminase status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Transglutaminase market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Transglutaminase significant trends, drivers, influence factors in global and regions.

6. To analyze Transglutaminase competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Transglutaminase market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Transglutaminase and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Transglutaminase.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Transglutaminase market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Transglutaminase industry.

Chapter 3: Detailed analysis of Transglutaminase manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Transglutaminase in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Transglutaminase in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Transglutaminase Industry Trends Table 2. Transglutaminase Industry Drivers Table 3. Transglutaminase Industry Opportunities and Challenges Table 4. Transglutaminase Industry Restraints Table 5. Global Transglutaminase Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Transglutaminase Revenue Share by Company (2021-2026) Table 7. Global Transglutaminase Sales Volume by Company (MT) & (2021-2026) Table 8. Global Transglutaminase Sales Volume Share by Company (2021-2026) Table 9. Global Transglutaminase Average Price (US$/Kg) of Company (2021-2026) Table 10. Global Transglutaminase Company Ranking, (2024-2026) & (USD Million) Table 11. Global Transglutaminase Key Company Manufacturing Base & Headquarters Table 12. Global Transglutaminase Company, Product Type & Application Table 13. Global Transglutaminase Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Transglutaminase by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Less Than 100 U/g Table 18. Significant Companies of 100 U/g – 200 U/g Table 19. Significant Companies of More Than 200 U/g Table 20. Global Transglutaminase Sales Volume by Type 2021 VS 2025 VS 2032 (MT) Table 21. Global Transglutaminase Sales Volume by Type (2021-2026) & (MT) Table 22. Global Transglutaminase Sales Volume by Type (2027-2032) & (MT) Table 23. Global Transglutaminase Sales Volume Share by Type (2021-2026) Table 24. Global Transglutaminase Sales Volume Share by Type (2027-2032) Table 25. Global Transglutaminase Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Transglutaminase Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Transglutaminase Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Transglutaminase Sales Value Share by Type (2021-2026) Table 29. Global Transglutaminase Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Meat Table 31. Significant Companies of Fish Table 32. Significant Companies of Dairy Table 33. Significant Companies of Flour Table 34. Significant Companies of Others Table 35. Global Transglutaminase Sales Volume by Application 2021 VS 2025 VS 2032 (MT) Table 36. Global Transglutaminase Sales Volume by Application (2021-2026) & (MT) Table 37. Global Transglutaminase Sales Volume by Application (2027-2032) & (MT) Table 38. Global Transglutaminase Sales Volume Share by Application (2021-2026) Table 39. Global Transglutaminase Sales Volume Share by Application (2027-2032) Table 40. Global Transglutaminase Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Transglutaminase Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global Transglutaminase Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global Transglutaminase Sales Value Share by Application (2021-2026) Table 44. Global Transglutaminase Sales Value Share by Application (2027-2032) Table 45. Global Transglutaminase Sales by Region: 2021 VS 2025 VS 2032 (MT) Table 46. Global Transglutaminase Sales by Region (2021-2026) & (MT) Table 47. Global Transglutaminase Sales Market Share by Region (2021-2026) Table 48. Global Transglutaminase Sales by Region (2027-2032) & (MT) Table 49. Global Transglutaminase Sales Market Share by Region (2027-2032) Table 50. Global Transglutaminase Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Transglutaminase Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global Transglutaminase Sales Value Share by Region (2021-2026) Table 53. Global Transglutaminase Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global Transglutaminase Sales Value Share by Region (2027-2032) Table 55. Global Transglutaminase Market Average Price (US$/Kg) by Region (2021-2026) Table 56. Global Transglutaminase Market Average Price (US$/Kg) by Region (2027-2032) Table 57. Global Transglutaminase Sales by Country: 2021 VS 2025 VS 2032 (MT) Table 58. Global Transglutaminase Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Transglutaminase Sales by Country (2021-2026) & (MT) Table 60. Global Transglutaminase Sales Market Share by Country (2021-2026) Table 61. Global Transglutaminase Sales by Country (2027-2032) & (MT) Table 62. Global Transglutaminase Sales Market Share by Country (2027-2032) Table 63. Global Transglutaminase Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global Transglutaminase Sales Value Market Share by Country (2021-2026) Table 65. Global Transglutaminase Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global Transglutaminase Sales Value Market Share by Country (2027-2032) Table 67. Ajinomoto Company Information Table 68. Ajinomoto Business Overview Table 69. Ajinomoto Transglutaminase Sales (MT), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 70. Ajinomoto Transglutaminase Product Portfolio Table 71. Ajinomoto Recent Development Table 72. TFI GmbH Company Information Table 73. TFI GmbH Business Overview Table 74. TFI GmbH Transglutaminase Sales (MT), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 75. TFI GmbH Transglutaminase Product Portfolio Table 76. TFI GmbH Recent Development Table 77. Micro-Tech Foods Ingredients Company Information Table 78. Micro-Tech Foods Ingredients Business Overview Table 79. Micro-Tech Foods Ingredients Transglutaminase Sales (MT), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 80. Micro-Tech Foods Ingredients Transglutaminase Product Portfolio Table 81. Micro-Tech Foods Ingredients Recent Development Table 82. BDF Natural Ingredients Company Information Table 83. BDF Natural Ingredients Business Overview Table 84. BDF Natural Ingredients Transglutaminase Sales (MT), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 85. BDF Natural Ingredients Transglutaminase Product Portfolio Table 86. BDF Natural Ingredients Recent Development Table 87. Yiming Biological Company Information Table 88. Yiming Biological Business Overview Table 89. Yiming Biological Transglutaminase Sales (MT), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 90. Yiming Biological Transglutaminase Product Portfolio Table 91. Yiming Biological Recent Development Table 92. Taixing Dongsheng Company Information Table 93. Taixing Dongsheng Business Overview Table 94. Taixing Dongsheng Transglutaminase Sales (MT), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 95. Taixing Dongsheng Transglutaminase Product Portfolio Table 96. Taixing Dongsheng Recent Development Table 97. Kinry Company Information Table 98. Kinry Business Overview Table 99. Kinry Transglutaminase Sales (MT), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 100. Kinry Transglutaminase Product Portfolio Table 101. Kinry Recent Development Table 102. Pangbo Biological Company Information Table 103. Pangbo Biological Business Overview Table 104. Pangbo Biological Transglutaminase Sales (MT), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 105. Pangbo Biological Transglutaminase Product Portfolio Table 106. Pangbo Biological Recent Development Table 107. Key Raw Materials Table 108. Raw Materials Key Suppliers Table 109. Transglutaminase Distributors List Table 110. Transglutaminase Customers List Table 111. Research Programs/Design for This Report Table 112. Authors List of This Report Table 113. Secondary Sources Table 114. Primary Sources List of Figures Figure 1. Transglutaminase Product Image Figure 2. Global Transglutaminase Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Transglutaminase Sales Value (2021-2032) & (US$ Million) Figure 4. Global Transglutaminase Sales (2021-2032) & (MT) Figure 5. Global Transglutaminase Sales Average Price (US$/Kg) & (2021-2032) Figure 6. Global Transglutaminase Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Less Than 100 U/g Image Figure 10. 100 U/g – 200 U/g Image Figure 11. More Than 200 U/g Image Figure 12. Global Transglutaminase Sales Volume by Type (2021 VS 2025 VS 2032) & (MT) Figure 13. Global Transglutaminase Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Transglutaminase Sales Volume Share by Type (2021-2032) Figure 15. Global Transglutaminase Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Transglutaminase Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Transglutaminase Sales Value Share by Type (2021-2032) Figure 18. Meat Image Figure 19. Fish Image Figure 20. Dairy Image Figure 21. Flour Image Figure 22. Others Image Figure 23. Global Transglutaminase Sales Volume by Application (2021 VS 2025 VS 2032) & (MT) Figure 24. Global Transglutaminase Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global Transglutaminase Sales Volume Share by Application (2021-2032) Figure 26. Global Transglutaminase Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Transglutaminase Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global Transglutaminase Sales Value Share by Application (2021-2032) Figure 29. Global Transglutaminase Sales by Region: 2021 VS 2025 VS 2032 (MT) Figure 30. Global Transglutaminase Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global Transglutaminase Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global Transglutaminase Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America Transglutaminase Sales Value (2021-2032) & (US$ Million) Figure 34. North America Transglutaminase Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe Transglutaminase Sales Value (2021-2032) & (US$ Million) Figure 36. Europe Transglutaminase Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific Transglutaminase Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Transglutaminase Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America Transglutaminase Sales Value (2021-2032) & (US$ Million) Figure 40. South America Transglutaminase Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa Transglutaminase Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa Transglutaminase Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA Transglutaminase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA Transglutaminase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA Transglutaminase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada Transglutaminase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada Transglutaminase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada Transglutaminase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico Transglutaminase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico Transglutaminase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico Transglutaminase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany Transglutaminase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany Transglutaminase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany Transglutaminase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France Transglutaminase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France Transglutaminase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France Transglutaminase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. Transglutaminase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. Transglutaminase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. Transglutaminase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy Transglutaminase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy Transglutaminase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy Transglutaminase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain Transglutaminase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain Transglutaminase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain Transglutaminase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia Transglutaminase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia Transglutaminase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia Transglutaminase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands Transglutaminase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands Transglutaminase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands Transglutaminase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries Transglutaminase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries Transglutaminase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries Transglutaminase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China Transglutaminase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China Transglutaminase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China Transglutaminase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan Transglutaminase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan Transglutaminase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan Transglutaminase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea Transglutaminase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea Transglutaminase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea Transglutaminase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India Transglutaminase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India Transglutaminase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India Transglutaminase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia Transglutaminase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia Transglutaminase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia Transglutaminase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia Transglutaminase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia Transglutaminase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia Transglutaminase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil Transglutaminase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil Transglutaminase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil Transglutaminase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina Transglutaminase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina Transglutaminase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina Transglutaminase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile Transglutaminase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile Transglutaminase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile Transglutaminase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia Transglutaminase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia Transglutaminase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia Transglutaminase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru Transglutaminase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru Transglutaminase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru Transglutaminase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Transglutaminase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia Transglutaminase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Transglutaminase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel Transglutaminase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia Transglutaminase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia Transglutaminase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE Transglutaminase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE Transglutaminase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE Transglutaminase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey Transglutaminase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey Transglutaminase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey Transglutaminase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran Transglutaminase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran Transglutaminase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran Transglutaminase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt Transglutaminase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt Transglutaminase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt Transglutaminase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Transglutaminase Value Chain Figure 128. Manufacturing Cost Structure Figure 129. Transglutaminase Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • Less Than 100 U/g
  • 100 U/g – 200 U/g
  • More Than 200 U/g
Applications
  • Meat
  • Fish
  • Dairy
  • Flour
  • Others
Companies covered
  • Ajinomoto
  • TFI GmbH
  • Micro-Tech Foods Ingredients
  • BDF Natural Ingredients
  • Yiming Biological
  • Taixing Dongsheng
  • Kinry
  • Pangbo Biological

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Transglutaminase Sales Value (2021-2032)
  4. 1.2.2 Global Transglutaminase Sales Volume (2021-2032)
  5. 1.2.3 Global Transglutaminase Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Transglutaminase Market Dynamics
  1. 2.1 Transglutaminase Industry Trends
  2. 2.2 Transglutaminase Industry Drivers
  3. 2.3 Transglutaminase Industry Opportunities and Challenges
  4. 2.4 Transglutaminase Industry Restraints
3 Transglutaminase Market by Company
  1. 3.1 Global Transglutaminase Company Revenue Ranking in 2025
  2. 3.2 Global Transglutaminase Revenue by Company (2021-2026)
  3. 3.3 Global Transglutaminase Sales Volume by Company (2021-2026)
  4. 3.4 Global Transglutaminase Average Price by Company (2021-2026)
  5. 3.5 Global Transglutaminase Company Ranking (2024-2026)
  6. 3.6 Global Transglutaminase Company Manufacturing Base and Headquarters
  7. 3.7 Global Transglutaminase Company Product Type and Application
  8. 3.8 Global Transglutaminase Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Transglutaminase Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Transglutaminase Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Transglutaminase Market by Type
  1. 4.1 Transglutaminase Type Introduction
  2. 4.1.1 Less Than 100 U/g
  3. 4.1.2 100 U/g – 200 U/g
  4. 4.1.3 More Than 200 U/g
  5. 4.2 Global Transglutaminase Sales Volume by Type
  6. 4.2.1 Global Transglutaminase Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Transglutaminase Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Transglutaminase Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Transglutaminase Sales Value by Type
  10. 4.3.1 Global Transglutaminase Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Transglutaminase Sales Value by Type (2021-2032)
  12. 4.3.3 Global Transglutaminase Sales Value Share by Type (2021-2032)
5 Transglutaminase Market by Application
  1. 5.1 Transglutaminase Application Introduction
  2. 5.1.1 Meat
  3. 5.1.2 Fish
  4. 5.1.3 Dairy
  5. 5.1.4 Flour
  6. 5.1.5 Others
  7. 5.2 Global Transglutaminase Sales Volume by Application
  8. 5.2.1 Global Transglutaminase Sales Volume by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Transglutaminase Sales Volume by Application (2021-2032)
  10. 5.2.3 Global Transglutaminase Sales Volume Share by Application (2021-2032)
  11. 5.3 Global Transglutaminase Sales Value by Application
  12. 5.3.1 Global Transglutaminase Sales Value by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Transglutaminase Sales Value by Application (2021-2032)
  14. 5.3.3 Global Transglutaminase Sales Value Share by Application (2021-2032)
6 Transglutaminase Regional Sales and Value Analysis
  1. 6.1 Global Transglutaminase Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Transglutaminase Sales by Region (2021-2032)
  3. 6.2.1 Global Transglutaminase Sales by Region: 2021-2026
  4. 6.2.2 Global Transglutaminase Sales by Region (2027-2032)
  5. 6.3 Global Transglutaminase Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Transglutaminase Sales Value by Region (2021-2032)
  7. 6.4.1 Global Transglutaminase Sales Value by Region: 2021-2026
  8. 6.4.2 Global Transglutaminase Sales Value by Region (2027-2032)
  9. 6.5 Global Transglutaminase Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Transglutaminase Sales Value (2021-2032)
  12. 6.6.2 North America Transglutaminase Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Transglutaminase Sales Value (2021-2032)
  15. 6.7.2 Europe Transglutaminase Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Transglutaminase Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Transglutaminase Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Transglutaminase Sales Value (2021-2032)
  21. 6.9.2 South America Transglutaminase Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Transglutaminase Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Transglutaminase Sales Value Share by Country, 2025 VS 2032
7 Transglutaminase Country-level Sales and Value Analysis
  1. 7.1 Global Transglutaminase Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Transglutaminase Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Transglutaminase Sales by Country (2021-2032)
  4. 7.3.1 Global Transglutaminase Sales by Country (2021-2026)
  5. 7.3.2 Global Transglutaminase Sales by Country (2027-2032)
  6. 7.4 Global Transglutaminase Sales Value by Country (2021-2032)
  7. 7.4.1 Global Transglutaminase Sales Value by Country (2021-2026)
  8. 7.4.2 Global Transglutaminase Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Transglutaminase Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Transglutaminase Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Transglutaminase Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Transglutaminase Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Transglutaminase Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Transglutaminase Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Transglutaminase Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Transglutaminase Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Transglutaminase Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Transglutaminase Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Transglutaminase Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Transglutaminase Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Transglutaminase Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Transglutaminase Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Transglutaminase Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Transglutaminase Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Transglutaminase Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Transglutaminase Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Transglutaminase Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Transglutaminase Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Transglutaminase Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Transglutaminase Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Transglutaminase Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Transglutaminase Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Transglutaminase Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Transglutaminase Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Transglutaminase Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Transglutaminase Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Transglutaminase Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Transglutaminase Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Transglutaminase Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Transglutaminase Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Transglutaminase Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Transglutaminase Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Transglutaminase Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Transglutaminase Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Transglutaminase Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Transglutaminase Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Transglutaminase Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Transglutaminase Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Transglutaminase Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Transglutaminase Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Transglutaminase Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Transglutaminase Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Transglutaminase Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Transglutaminase Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Transglutaminase Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Transglutaminase Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Transglutaminase Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Transglutaminase Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Transglutaminase Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Transglutaminase Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Transglutaminase Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Transglutaminase Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Transglutaminase Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Transglutaminase Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Transglutaminase Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Transglutaminase Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Transglutaminase Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Transglutaminase Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Transglutaminase Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Transglutaminase Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Transglutaminase Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Transglutaminase Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Transglutaminase Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Transglutaminase Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Transglutaminase Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Transglutaminase Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Transglutaminase Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Transglutaminase Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Transglutaminase Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Transglutaminase Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Transglutaminase Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Transglutaminase Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Transglutaminase Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Transglutaminase Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Transglutaminase Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Transglutaminase Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Transglutaminase Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Transglutaminase Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Transglutaminase Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Transglutaminase Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Transglutaminase Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Transglutaminase Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Ajinomoto
  2. 8.1.1 Ajinomoto Company Information
  3. 8.1.2 Ajinomoto Business Overview
  4. 8.1.3 Ajinomoto Transglutaminase Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Ajinomoto Transglutaminase Product Portfolio
  6. 8.1.5 Ajinomoto Recent Developments
  7. 8.2 TFI GmbH
  8. 8.2.1 TFI GmbH Company Information
  9. 8.2.2 TFI GmbH Business Overview
  10. 8.2.3 TFI GmbH Transglutaminase Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 TFI GmbH Transglutaminase Product Portfolio
  12. 8.2.5 TFI GmbH Recent Developments
  13. 8.3 Micro-Tech Foods Ingredients
  14. 8.3.1 Micro-Tech Foods Ingredients Company Information
  15. 8.3.2 Micro-Tech Foods Ingredients Business Overview
  16. 8.3.3 Micro-Tech Foods Ingredients Transglutaminase Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Micro-Tech Foods Ingredients Transglutaminase Product Portfolio
  18. 8.3.5 Micro-Tech Foods Ingredients Recent Developments
  19. 8.4 BDF Natural Ingredients
  20. 8.4.1 BDF Natural Ingredients Company Information
  21. 8.4.2 BDF Natural Ingredients Business Overview
  22. 8.4.3 BDF Natural Ingredients Transglutaminase Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 BDF Natural Ingredients Transglutaminase Product Portfolio
  24. 8.4.5 BDF Natural Ingredients Recent Developments
  25. 8.5 Yiming Biological
  26. 8.5.1 Yiming Biological Company Information
  27. 8.5.2 Yiming Biological Business Overview
  28. 8.5.3 Yiming Biological Transglutaminase Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Yiming Biological Transglutaminase Product Portfolio
  30. 8.5.5 Yiming Biological Recent Developments
  31. 8.6 Taixing Dongsheng
  32. 8.6.1 Taixing Dongsheng Company Information
  33. 8.6.2 Taixing Dongsheng Business Overview
  34. 8.6.3 Taixing Dongsheng Transglutaminase Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Taixing Dongsheng Transglutaminase Product Portfolio
  36. 8.6.5 Taixing Dongsheng Recent Developments
  37. 8.7 Kinry
  38. 8.7.1 Kinry Company Information
  39. 8.7.2 Kinry Business Overview
  40. 8.7.3 Kinry Transglutaminase Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Kinry Transglutaminase Product Portfolio
  42. 8.7.5 Kinry Recent Developments
  43. 8.8 Pangbo Biological
  44. 8.8.1 Pangbo Biological Company Information
  45. 8.8.2 Pangbo Biological Business Overview
  46. 8.8.3 Pangbo Biological Transglutaminase Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Pangbo Biological Transglutaminase Product Portfolio
  48. 8.8.5 Pangbo Biological Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Transglutaminase Value Chain Analysis
  2. 9.1.1 Transglutaminase Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Transglutaminase Sales Mode & Process
  6. 9.2 Transglutaminase Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Transglutaminase Distributors
  9. 9.2.3 Transglutaminase Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst